These results suggest that the combination of sorafenib and TMZ could induce ROS and that ROS played an important role in cell apoptosis and inhibition of JAK2/STAT3 induced by the combination of sorafenib and TMZ in glioma cells. This evidence concerns the gene STAT3 and central nervous system cancer.